General Information of Drug (ID: DM7H7NR)

Drug Name
Hepcidin
Indication
Disease Entry ICD 11 Status REF
Hemochromatosis 5C64.1Y Phase 1 [1]
Cross-matching ID
PubChem CID
91864521
TTD ID
D03WWW

References

1 A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia. J Hematol Oncol. 2017 Mar 21;10(1):73.